Publication:
VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.

Simple item page
dc.contributor.authorsCabuk, D; Basaran, G; Yumuk, PF; Celikel, C; Dane, F; Iyikesici, MS; Ekenel, M; Turhal, NS
dc.date.accessioned2022-03-12T15:59:02Z
dc.date.accessioned2026-01-11T17:27:46Z
dc.date.available2022-03-12T15:59:02Z
dc.date.issued2005
dc.identifier.doidoiWOS:000230326602090
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224262
dc.identifier.wosWOS:000230326602090
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleVEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage317S
oaire.citation.issue16
oaire.citation.startPage317S
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume23

Files

Collections

Araştırma Çıktıları